Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Virally targeted therapies for EBV-associated malignancies.

Oncogene - 11 Aug 2003

Israel Bruce F, Kenney Shannon C

Abstract excerpt

In Epstein-Barr virus (EBV)-positive lymphomas, the presence of the EBV genome in virtually all tumor cells, but very few normal cells, suggests that novel, EBV-targeted therapies could be used to treat these malignancies. In this paper, we review a variety of different approaches currently under development that specifically target EBV-infected cells for destruction. EBV-based strategies for treating cancer...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antigens
Share to Chromatin
Share to Ganciclovir

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Gene Transfer Techniques

Share to Genes, Viral

Share to Herpesvirus 4, Human

Share to Tumor Cells, Cultured

Share to Up-Regulation

Source

Identifiers

PMID: 12910249
DOI: 10.1038/sj.onc.1206548

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Virally targeted therapies for EBV-associated malignancies.PMID 12910249Read ↗

Therapies based on targeting Epstein‐Barr virus lytic replication for EBV ‐associated malignanciesSemantic proximity Read ↗

Targeting EBV Episome for Anti-Cancer Therapy: Emerging Strategies and ChallengesSemantic proximity Read ↗

Epstein–Barr virus infection: basis of malignancy and potential for therapySemantic proximity Read ↗

Epstein–Barr Virus (EBV) Epithelial Associated Malignancies: Exploring Pathologies and Current TreatmentsSemantic proximity Read ↗

Epstein-Barr virus (EBV) and its associated human cancers--genetics, epigenetics, pathobiology and novel therapeutics.Semantic proximity Read ↗

Immunotherapeutic strategies for EBV-associated malignancies.Semantic proximity Read ↗

Beyond immortality: Epstein–Barr virus and the intricate dance of programmed cell death in cancer developmentSemantic proximity Read ↗

Advancing therapeutic strategies for Epstein-Barr virus-associated malignancies through lytic reactivationSemantic proximity Read ↗

Progress in Prophylactic and Therapeutic EBV Vaccine Development Based on Molecular Characteristics of EBV Target AntigensSemantic proximity Read ↗

Immune Modulation by Epstein–Barr Virus Lytic Cycle: Relevance and Implication in OncogenesisSemantic proximity Read ↗

Epstein‐Barr Virus: The First Human Tumor Virus and its Role in CancerSemantic proximity Read ↗

Molecular mechanisms of EBV-driven cell cycle progression and oncogenesisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.